This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RABBIT ANTI HUMAN CD156b (C-TERMINAL)
catalog :
AHP589
quantity :
0.1 mg
price :
348 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
Region :
(C-TERMINAL)
ProductCode :
AHP589
Description :
RABBIT ANTI HUMAN CD156b (C-TERMINAL)
Specificity :
CD156b
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
ApplicationTypes :
Western Blotting
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0001666,GO:0001934,GO:0002446,GO:0002467,GO:0004222,GO:0005887,GO:0005138,GO:0005178,GO:0005737,GO:0007173,GO:0007219,GO:0008270,GO:0008284,GO:0042493,GO:0009986,GO:0010820,GO:0015629,GO:0016324,GO:0017124,GO:0055099,GO:0048536,GO:0051088,GO:0030165,GO:0030183,GO:0030307,GO:0030511,GO:0031293,GO:0031659,GO:0032496,GO:0032717,GO:0032722,GO:0033025,GO:0033077,GO:0033627,GO:0035313,GO:0035625,GO:0045121,GO:0048011
GOTerms :
response to hypoxic stress,response to lowered oxygen tension,activation of protein amino acid phosphorylation,positive regulation of protein amino acid phosphorylation,stimulation of protein amino acid phosphorylation,up regulation of protein amino acid phosphorylation,upregulation of protein amino acid phosphorylation,up-regulation of protein amino acid phosphorylation,metalloendoprotease activity,metalloendoproteinase activity,IL-6,interleukin-6 receptor ligand,integrin ligand,EGF receptor signaling pathway,EGF receptor signalling pathway,EGFR signaling pathway,epidermal growth factor receptor signalling pathway,GO:0030179,N signaling pathway,N signalling pathway,Notch receptor signaling pathway,Notch receptor signalling pathway,Notch signalling pathway,Notch-receptor signaling pathway,Notch-receptor signalling pathway,zinc binding,activation of cell proliferation,stimulation of cell proliferation,up regulation of cell proliferation,upregulation of cell proliferation,up-regulation of cell proliferation,drug resistance,drug susceptibility/resistance,GO:0017035,cell associated,cell bound,GO:0009928,GO:0009929,DHR-domain binding,GLGF-domain binding,B cell development,B lymphocyte differentiation,B-cell differentiation,B-lymphocyte differentiation,GO:0042115,activation of cell growth,stimulation of cell growth,up regulation of cell growth,upregulation of cell growth,up-regulation of cell growth,activation of transforming growth factor beta receptor signaling pathway,positive regulation of TGFbeta receptor signaling pathway,positive regulation of TGF-beta receptor signaling pathway,positive regulation of transforming growth factor beta receptor signalling pathway,stimulation of transforming growth factor beta receptor signaling pathway,up regulation of transforming growth factor beta receptor signaling pathway,upregulation of transforming growth factor beta receptor signaling pathway,up-regulation of transforming growth factor beta receptor signaling pathway,membrane protein solubilization,G1/S-specific activation of cyclin-dependent protein kinase activity,G1/S-specific positive regulation of cyclin-dependent protein kinase activity,G1/S-specific stimulation of cyclin-dependent protein kinase activity,G1/S-specific up regulation of cyclin-dependent protein kinase activity,G1/S-specific up-regulation of cyclin-dependent protein kinase activity,G1/S-specific upregulation of cyclin-dependent protein kinase activity,positive regulation of cyclin-dependent protein kinase activity during G1/S,response to endotoxin,response to LPS,down regulation of interleukin-8 production,down-regulation of interleukin-8 production,downregulation of interleukin-8 production,inhibition of interleukin-8 production,negative regulation of IL-8 production,activation of chemokine production,stimulation of chemokine production,up regulation of chemokine production,upregulation of chemokine production,up-regulation of chemokine production,T cell development in thymus,thymic T cell differentiation,thymocyte cell differentiation,thymocyte differentiation,cell adhesion mediated by integrin complex,EGFR transactivation by GPCR,EGFR transactivation upon GPCR stimulation,GEM domain,glycolipid-enriched membrane domain,lipid raft,nerve growth factor receptor signalling pathway,NGF receptor signaling pathway,NGF receptor signalling pathway,response to high density lipoprotein particle stimulus
Uniprot Accessions :
P78536
Gene :
ADAM17
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6868
Published Synonyms :
ADAM-17,TACE
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
248
PriceEUR :
348
PriceUSD :
348 USD
PriceCHF :
379
PriceSEK :
3793
PriceNOK :
3812
PriceDKK :
2595
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.